New miRNA test could spot hidden virus after transplant

NCT ID NCT07210242

Not yet recruiting Diagnosis Sponsor: Ting YANG Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test a new blood test that looks for tiny molecules called miRNAs to detect HCMV infection earlier in people who have received a stem cell transplant. The standard DNA test can miss early signs, so researchers hope this new method will give doctors a head start. About 300 patients in China will participate, and their blood will be checked before and after transplant to compare the two tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PSTM-qPCR miRNA detection technology
What this could lead to: If successful, this could provide a faster, more accurate way to detect HCMV infection after stem cell transplant, allowing earlier treatment and potentially reducing complications.
What could go wrong: This is an observational study, not a treatment trial. The new test may not prove more effective than current DNA testing, and results may not apply outside the study centers in China.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cytomegalovirus infection disease disease arising from reactivation of latent virus graft versus host disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CYTOMEGALOVIRUS INFECTIONS GRAFT VS HOST DISEASE HEMATOPOIETIC STEM CELL TRANSPLANTATION VIRUS REACTIVATION

More trials for these conditions

Other studies related to the condition(s) this trial covers.